Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Peripheral arterial disease as an independent predictor for excess stroke morbidity and mortality in primary-care patients: 5-year results of the getABI study.
Meves SH, Diehm C, Berger K, Pittrow D, Trampisch HJ, Burghaus I, Tepohl G, Allenberg JR, Endres HG, Schwertfeger M, Darius H, Haberl RL; getABI Study Group. Meves SH, et al. Among authors: schwertfeger m. Cerebrovasc Dis. 2010;29(6):546-54. doi: 10.1159/000306640. Epub 2010 Apr 8. Cerebrovasc Dis. 2010. PMID: 20375496
Health State In Patients With Atrial Fibrillation On New Oral Anticoagulants As Assessed With The New Eq-5d-5l Questionnaire At Baseline And 12-Month Follow-Up: Prefer In Af Registry.
Brüggenjürgen B, Schliephacke T, Darius H, De CR, Le HJ, Reimitz PE, Schilling RJ, Schwertfeger M, Zamorano JL, Kirchhof P. Brüggenjürgen B, et al. Among authors: schwertfeger m. Value Health. 2014 Nov;17(7):A493. doi: 10.1016/j.jval.2014.08.1464. Epub 2014 Oct 26. Value Health. 2014. PMID: 27201472 Free article. No abstract available.
Treatment Satisfaction In Patients With Atrial Fibrillation On New Oral Anticoagulants As Assessed With Pact-Q2 At Baseline And 12-Month Follow-Up: Prefer In Af Registry.
Brüggenjürgen B, Schliephacke T, Darius H, De CR, Le HJ, Reimitz PE, Schilling RJ, Schwertfeger M, Zamorano JL, Kirchhof P. Brüggenjürgen B, et al. Among authors: schwertfeger m. Value Health. 2014 Nov;17(7):A497. doi: 10.1016/j.jval.2014.08.1484. Epub 2014 Oct 26. Value Health. 2014. PMID: 27201497 Free article. No abstract available.
In Germany diabetic patients with coronary artery disease are treated more intensively than diabetic patients with other manifestations of atherothrombosis--results from the REACH registry.
Parhofer KG, Zeymer U, Stark RG, Binz C, Schwertfeger M, Bhatt DL, Steg PG, Röther J; REACH Registry Investigators. Parhofer KG, et al. Among authors: schwertfeger m. Exp Clin Endocrinol Diabetes. 2010 Jan;118(1):51-6. doi: 10.1055/s-0029-1225648. Epub 2009 Oct 15. Exp Clin Endocrinol Diabetes. 2010. PMID: 19834877
Updated European Heart Rhythm Association practical guide on the use of non-vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation: Executive summary.
Heidbuchel H, Verhamme P, Alings M, Antz M, Diener HC, Hacke W, Oldgren J, Sinnaeve P, Camm AJ, Kirchhof P; ESC Scientific Document Group. Heidbuchel H, et al. Eur Heart J. 2017 Jul 14;38(27):2137-2149. doi: 10.1093/eurheartj/ehw058. Eur Heart J. 2017. PMID: 27282612 Free PMC article.
18 results